Close

This is a StreetInsider.com Premium Only Page

Please sign-up to enjoy all the benefits of StreetInsider.com Premium or log-in if you're already a member.

Send to a Friend Font Size: Increase Decrease

Back to ADXN Stock Lookup

(ADXN) – FDA

May 10, 2023 04:13 AM Addex Therapeutics (ADXN) Announces IRC Recommended to Continue ADX71149 Phase 2 Epilepsy Study
May 27, 2022 05:47 AM Addex Therapeutics (ADXN) Announces Phase 2 Study of Dipraglurant Did Not Show Conclusive Effects
Apr 6, 2022 05:51 AM
Nov 15, 2021 05:47 AM
Sep 29, 2021 06:05 AM
Jun 7, 2021 05:59 AM
Jan 21, 2021 06:10 AM

Back to ADXN Stock Lookup